300 related articles for article (PubMed ID: 29617672)
1. Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus.
Roth SH; Danan-Gotthold M; Ben-Izhak M; Rechavi G; Cohen CJ; Louzoun Y; Levanon EY
Cell Rep; 2018 Apr; 23(1):50-57. PubMed ID: 29617672
[TBL] [Abstract][Full Text] [Related]
2. Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
Laxminarayana D; O'Rourke KS; Maas S; Olorenshaw I
Immunology; 2007 Jul; 121(3):359-69. PubMed ID: 17376196
[TBL] [Abstract][Full Text] [Related]
3. Regulation of RNA editing by RNA-binding proteins in human cells.
Quinones-Valdez G; Tran SS; Jun HI; Bahn JH; Yang EW; Zhan L; Brümmer A; Wei X; Van Nostrand EL; Pratt GA; Yeo GW; Graveley BR; Xiao X
Commun Biol; 2019; 2():19. PubMed ID: 30652130
[TBL] [Abstract][Full Text] [Related]
4. Altered editing in cyclic nucleotide phosphodiesterase 8A1 gene transcripts of systemic lupus erythematosus T lymphocytes.
Orlowski RJ; O'Rourke KS; Olorenshaw I; Hawkins GA; Maas S; Laxminarayana D
Immunology; 2008 Nov; 125(3):408-19. PubMed ID: 18462347
[TBL] [Abstract][Full Text] [Related]
5. Transcript mutations of the alpha regulatory subunit of protein kinase A and up-regulation of the RNA-editing gene transcript in lupus T lymphocytes.
Laxminarayana D; Khan IU; Kammer G
Lancet; 2002 Sep; 360(9336):842-9. PubMed ID: 12243919
[TBL] [Abstract][Full Text] [Related]
6. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.
Li QZ; Zhou J; Wandstrat AE; Carr-Johnson F; Branch V; Karp DR; Mohan C; Wakeland EK; Olsen NJ
Clin Exp Immunol; 2007 Jan; 147(1):60-70. PubMed ID: 17177964
[TBL] [Abstract][Full Text] [Related]
7. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
Bolouri N; Akhtari M; Farhadi E; Mansouri R; Faezi ST; Jamshidi A; Mahmoudi M
Inflamm Res; 2022 Jun; 71(5-6):537-554. PubMed ID: 35298669
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
Wang C; Zou J; Ma X; Wang E; Peng G
Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus.
Lewis MJ; McAndrew MB; Wheeler C; Workman N; Agashe P; Koopmann J; Uddin E; Morris DL; Zou L; Stark R; Anson J; Cope AP; Vyse TJ
J Autoimmun; 2018 Jul; 91():1-12. PubMed ID: 29576246
[TBL] [Abstract][Full Text] [Related]
10. Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies.
Muslimov IA; Iacoangeli A; Eom T; Ruiz A; Lee M; Stephenson S; Ginzler EM; Tiedge H
J Neurosci; 2019 Sep; 39(39):7759-7777. PubMed ID: 31405929
[TBL] [Abstract][Full Text] [Related]
11. MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus.
Ugarte-Berzal E; Boon L; Martens E; Rybakin V; Blockmans D; Vandooren J; Proost P; Opdenakker G
Front Immunol; 2019; 10():538. PubMed ID: 30967870
[TBL] [Abstract][Full Text] [Related]
12. Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium.
Prechl J; Papp K; Hérincs Z; Péterfy H; Lóránd V; Szittner Z; Estonba A; Rovero P; Paolini I; Del Amo J; Uribarri M; Alcaro MC; Ruiz-Larrañaga O; Migliorini P; Czirják L
PLoS One; 2016; 11(3):e0150685. PubMed ID: 26950932
[TBL] [Abstract][Full Text] [Related]
13. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
Long H; Yin H; Wang L; Gershwin ME; Lu Q
J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
[TBL] [Abstract][Full Text] [Related]
14. Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells.
Liao X; Reihl AM; Luo XM
J Immunol Res; 2016; 2016():6269157. PubMed ID: 27034965
[TBL] [Abstract][Full Text] [Related]
15. A-to-I RNA editing - thinking beyond the single nucleotide.
Ganem NS; Lamm AT
RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
[TBL] [Abstract][Full Text] [Related]
16. The fate of the U1 snRNP autoantigen during apoptosis: implications for systemic autoimmunity.
Malmegrim KC; Pruijn GJ; van Venrooij WJ
Isr Med Assoc J; 2002 Sep; 4(9):706-12. PubMed ID: 12440236
[TBL] [Abstract][Full Text] [Related]
17. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
Fritzell K; Xu LD; Lagergren J; Öhman M
Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
[TBL] [Abstract][Full Text] [Related]
18. How do ADARs bind RNA? New protein-RNA structures illuminate substrate recognition by the RNA editing ADARs.
Thomas JM; Beal PA
Bioessays; 2017 Apr; 39(4):. PubMed ID: 28217931
[TBL] [Abstract][Full Text] [Related]
19. The RNA editing enzymes ADARs: mechanism of action and human disease.
Tomaselli S; Locatelli F; Gallo A
Cell Tissue Res; 2014 Jun; 356(3):527-32. PubMed ID: 24770896
[TBL] [Abstract][Full Text] [Related]
20. B cell tolerance to epidermal ribonuclear-associated neo-autoantigen in vivo.
Degn SE; Alicot E; Carroll MC
Clin Exp Immunol; 2018 Feb; 191(2):151-165. PubMed ID: 28984923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
